How to Set Up a Perioperative BNP/NTproBNP and Troponin Screening Program

Main Article Content

Erin N. Sloan
Erin E. Morley

Perioperative Medicine, BNP/ NTproBNP, troponin

Abstract

Key Learning Points
1. Review the rationale and evidence to support the use of perioperative biomarkers (BNP/
NTproBNP and troponin)
2. Explore three unique models for integrating perioperative biomarkers into practice
3. Apply guiding principles to perform a site-specific assessment of the current approach to perioperative risk assessment and review strategies on how to initiate implementation of a perioperative biomarker screening program
4. Understand commonly faced challenges, and proposed solutions, for implementing a perioperative biomarker screening program
5. Appreciate the potential role for a shared-care model to facilitate perioperative biomarkers screening and management


 


Points à retenir
1. Examiner la justification et les données probantes à l’appui de l’utilisation de biomarqueurs périopératoires (BNP/NTproBNP et troponine).
2. Explorer trois modèles uniques pour l’intégration de biomarqueurs périopératoires dans la pratique.
3. Appliquer des principes directeurs pour réaliser une évaluation propre au site de l’approche actuelle en matière d’évaluation des risques périopératoires et examiner les stratégies sur la manière d’entreprendre la mise en œuvre d’un programme de dépistage périopératoire de biomarqueurs.
4. Comprendre les défis couramment affrontés et les solutions proposées pour la mise en œuvre d’un
programme de dépistage périopératoire de biomarqueurs. 5. Prendre la mesure du rôle potentiel d’un modèle de
partage des soins pour faciliter le dépistage et la prise en charge de biomarqueurs périopératoires.

Abstract 179 | pdf Downloads 167 HTML Downloads 10

References

1. Weiser TG, Haynes AB, Molina G, et al. Estimate of the global volume of surgery in 2012: An assessment supporting improved health outcomes. Lancet. 2015 Apr 27;385(Suppl 2):S11. http://dx.doi.org/10.1016/S0140-6736(15)60806-6
2. Botto F, Alonso-Coello P, Chan MT, Villar JC, Xavier D, Srinathan S, et al. Myocardial injury after noncardiac surgery: A large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology. 2014;120:564–78. http://dx.doi.org/10.1097/ALN.0000000000000113
3. Fleisher LA, Fleishmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2014;130:e278–333. http://dx.doi.org/10.1161/CIR.0000000000000104
4. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA guidelines on non-cardiac surgery: Cardiovascular assessment and management. Eur Heart J. 2014;35:2383–431. http://dx.doi.org/10.1093/eurheartj/ehu282
5. Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. 2017;33:17–32. http://dx.doi.org/10.1016/j.cjca.2016.09.008
6. Duceppe E, Patel A, Chan MT, Berwanger O, Ackland G, Kavsak PA, et al. Preoperative N-terminal Pro–B-type natriuretic peptide and cardiovascular events after noncardiac surgery: A cohort study. Ann Intern Med. 2020 Jan 21;172(2):96–104. http://dx.doi.org/10.7326/L20-0269
7. Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Buse GA, Thabane L, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: A systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014 Jan 21;63(2):170–80. http://dx.doi.org/10.1016/j.jacc.2013.08.1630
8. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9. http://dx.doi.org/10.1161/01.CIR.100.10.1043
9. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:2215–45. http://dx.doi.org/10.1161/CIR.0000000000000105
10. Park SJ, Choi JH, Cho SJ, et al. Comparison of transthoracic echocardiography with N-terminal pro-brain natriuretic peptide as a tool for risk stratification of patients undergoing major noncardiac surgery. Korean Circ J. 2011;41:505–11. http://dx.doi.org/10.4070/kcj.2011.41.9.505
11. Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MT, Srinathan SK, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017 Apr 25;317(16):1642–51.
12. van Waes JA, Nathoe HM, de Graaff JC, Kemperman H, de Borst GJ, Peelen LM, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation. 2013 Jun 11;127(23):2264–71. http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002128
13. Beattie WS, Karkouti K, Tait G, Steel A, Yip P, McCluskey S, et al. Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: A single-centre cohort study in 51,701 consecutive patients. Can J Anesth. 2012 Nov 1;59(11):1013–22. http://dx.doi.org/10.1007/s12630-012-9782-9
14. Devereaux PJ, Szczeklik W. Myocardial injury after non-cardiac surgery: Diagnosis and management. Eur Heart J. 2020 May 1;41(32):3083–91. http://dx.doi.org/10.1093/eurheartj/ehz301
15. Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): An international, randomised, placebo-controlled trial. Lancet. 2018 Jun 9;391(10137):2325–34.
16. Foucrier A, Rodseth R, Aissaoui M, et al. The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery. Anesth Analg. 2014;119:1053. http://dx.doi.org/10.1213/ANE.0000000000000302
17. Buse GL, Manns B, Lamy A, Guyatt G, Polanczyk CA, Chan MT, et al. Troponin T monitoring to detect myocardial injury after noncardiac surgery: A cost–consequence analysis. Can J Surg. 2018 Jun;61(3):185. http://dx.doi.org/10.1503/cjs.010217
18. Shaw M, Pelecanos AM, Mudge AM. Evaluation of internal medicine physician or multidisciplinary team comanagement of surgical patients and clinical outcomes: A systematic review and meta-analysis. JAMA Netw Open. 2020 May 1;3(5):e204088. http://dx.doi.org/10.1001/jamanetworkopen.2020.4088
19. Kammerlander C, Roth T, Friedman SM, Suhm N, Luger TJ, Kammerlander-Knauer U, et al. Ortho-geriatric service—A literature review comparing different models. Osteoporos Int. 2010 Dec;21(Suppl 4):S637–46. http://dx.doi.org/10.1007/s00198-010-1396-x
20. Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: A systematic review and meta-analysis. J Orthop Trauma. 2014 Mar;28(3):e49–55. http://dx.doi.org/10.1097/BOT.0b013e3182a5a045
21. Huddleston JM, Long KH, Naessens JM, Vanness D, Larson D, Trousdale R, et al. Medical and surgical comanagement after elective hip and knee arthroplasty: A randomized, controlled trial. Ann Intern Med. 2004 Jul 6;141(1):28–38. http://dx.doi.org/10.7326/0003-4819-141-1-200407060-00012
22. Fisher AA, Davis MW, Rubenach SE, Sivakumaran S, Smith PN, Budge MM. Outcomes for older patients with hip fractures: The impact of orthopedic and geriatric medicine cocare. J Orthop Trauma. 2006 Mar;20(3):172–8; discussion 179–80. http://dx.doi.org/10.1097/01.bot.0000202220.88855.16
23. Rohatgi N, Loftus P, Grujic O, Cullen M, Hopkins J, Ahuja N. Surgical comanagement by hospitalists improves patient outcomes. Ann Surg. 2016 Aug 1;264(2):275–82. http://dx.doi.org/10.1097/SLA.0000000000001629
24. McKilligan K. Roche diagnostics, personal communication, November 19, 2020.
25. Roche Diagnostics.. Cardiac markers: Ane tube, standardized POC and laboratory, one complete solution for chest pain management. Laval, QB; 2012.
26. VPSA-funded project aims to improve perioperative cardiac risk evaluation and management for noncardiac surgery [Internet]. VMDAS Association Newsletter. 2018 Oct 16. Available from: https://ourvancouvermsa.ca/2018/10/16/vpsa-funded-project-aims-to-improve-perioperative-cardiac-risk-evaluation-and-management-for-noncardiac-surgery/